Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net loss attributable to Flotek Industries, Inc. (Flotek)	$ (32,279,000)	$ (70,340,000)	$ (27,395,000)
Income (loss) from discontinued operations, net of tax	44,456,000	2,743,000	(9,891,000)
Loss from continuing operations	(76,735,000)	(73,083,000)	(17,504,000)
Adjustments to reconcile loss from continuing operations to net cash (used in) provided by operating activities:
Depreciation and amortization	8,465,000	9,216,000	9,768,000
Amortization of deferred financing costs	1,428,000	400,000	472,000
Provision for doubtful accounts	512,000	839,000	157,000
Provision for excess and obsolete inventory	5,659,000	2,418,000	388,000
Loss on sale of business	0	360,000	0
Loss on write-down of assets held for sale	0	2,580,000	0
(Gain) loss on sale of assets	1,450,000	(443,000)	292,000
Impairment of goodwill	0	37,180,000	0
Stock compensation expense	4,235,000	7,050,000	10,643,000
Deferred income tax (benefit) provision	18,307,000	(5,950,000)	181,000
Reduction in tax benefit related to share-based awards	24,000	709,000	1,989,000
Non-cash lease expense	740,000	0	0
Changes in current assets and liabilities:
Accounts receivable, net	20,993,000	(2,606,000)	4,076,000
Inventories	(65,000)	2,597,000	(3,442,000)
Income taxes receivable	2,546,000	(1,116,000)	8,008,000
Other current assets	(8,359,000)	3,177,000	12,001,000
Accounts payable	1,131,000	4,631,000	(8,528,000)
Accrued liabilities	908,000	(8,740,000)	(6,175,000)
Interest payable	(8,000)	(35,000)	19,000
Net cash provided (used in) by operating activities	(18,769,000)	(20,816,000)	12,345,000
Cash flows from investing activities:
Capital expenditures	(2,411,000)	(3,559,000)	(4,197,000)
Proceeds from sale of businesses	169,722,000	1,665,000	18,490,000
Proceeds from sale of assets	240,000	1,387,000	689,000
Purchase of patents and other intangible assets	(614,000)	(1,602,000)	(456,000)
Net cash (used in) provided by investing activities	166,937,000	(2,109,000)	14,526,000
Cash flows from financing activities:
Repayments of indebtedness	0	0	(9,833,000)
Borrowings on revolving credit facility	42,984,000	277,599,000	383,160,000
Repayments on revolving credit facility	(92,715,000)	(255,818,000)	(393,776,000)
Debt issuance costs	0	(111,000)	(579,000)
Payments for finance leases	(51,000)	0	0
Purchase of treasury stock	(247,000)	(173,000)	(1,729,000)
Proceeds from sale of common stock	35,000	341,000	654,000
Repurchase of common stock	0	0	(5,203,000)
Proceeds from exercise of stock options	0	0	21,000
Loss from noncontrolling interest	0	(358,000)	0
Net cash provided by (used in) financing activities	(49,994,000)	21,480,000	(27,285,000)
Discontinued operations:
Net cash provided by (used in) operating activities	(322,000)	1,296,000	4,102,000
Net cash provided by (used in) investing activities	337,000	(1,303,000)	(4,078,000)
Net cash flows (used in) provided by discontinued operations	15,000	(7,000)	24,000
Effect of changes in exchange rates on cash and cash equivalents	5,000	(88,000)	151,000
Net change in cash, cash equivalents and restricted cash	98,194,000	(1,540,000)	(239,000)
Cash, cash equivalents and restricted cash at beginning of year	3,044,000	4,584,000	4,823,000
Cash, cash equivalents and restricted cash at end of year	$ 101,238,000	$ 3,044,000	$ 4,584,000